Bernstein analyst Lance Wilkes raised the firm's price target on Cigna to $371 from $358 and keeps an Outperform rating on the shares following quarterly results. The firm is updating its earnings model with EPS estimates roughly the same for 2026, and modestly higher for 2027 - 2030.
